Related Experiment Videos

Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A

Xiaofan Guo1, Guozhe Sun1, Ziyi Xie2

  • 1Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Journal of the American College of Cardiology
|July 8, 2026
PubMed

Insights

This study shows that a community health intervention significantly reduced cardiovascular risk, primarily by improving blood pressure (BP). Combined improvements in BP with behavioral or metabolic factors offered the greatest risk reduction.

Area of Science:

  • Cardiovascular Health
  • Public Health Interventions
  • Health Behavior Change

Background:

  • Cardiovascular health (CVH) assessment uses a multidimensional framework, with interventions targeting CVH metrics.
  • Patterns of CVH change and their link to clinical outcomes after interventions require further clarification.

Purpose of the Study:

  • To characterize CVH change patterns post-intervention.
  • To examine how multidimensional response domains from Life's Simple 7 relate to cardiovascular outcomes.

Main Methods:

  • Post hoc analysis of 26,700 participants in the China Rural Hypertension Control Project.
  • Intervention focused on intensive blood pressure (BP) management by nonphysician providers.
  • Longitudinal CVH changes analyzed across BP, metabolic, and behavioral domains; associations with cardiovascular outcomes assessed via Cox models.

Main Results:

  • Intervention improved LS7 scores and reduced cardiovascular risk (HR: 0.71).
  • Greatest risk reduction observed with BP improvement plus behavioral/metabolic gains (HR: 0.57), followed by BP improvement alone (HR: 0.76).
  • BP changes accounted for the majority of the effect (67.5%), with smaller contributions from behavioral (8.0%) and metabolic domains.

Conclusions:

  • A scalable, nonphysician-delivered intervention effectively reduced cardiovascular risk, primarily through BP management.
  • Heterogeneous, domain-specific responses were observed, with BP being the main driver of benefit.
  • Provides a quantitative framework for understanding multifaceted interventions' impact on cardiovascular outcomes.
Abstract

Keywords:
cardiovascular diseasecardiovascular healthdomain-specific patternsintensive blood pressure interventionlongitudinal changesmediation analysis

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...